Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: Comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimen

1. Jarrin, I.
2. Hernández-Novoa, B.
3. Alejos, B.
4. Santos, I.
5. Lopez-Aldeguer, J.
6. Riera, M.
7. Gutiérrez, F.
8. Rubio, R.
9. Antela, A.
10. Blanco, J.R.
11. Moreno, S.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1111/HIV.12144 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus